1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About ShockWave Medical Inc

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which Shockwave Medical refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes.
Douglas Godshall

5403 Betsy Ross Dr
Santa Clara, California 95054
Phone: 15102794262


TISSIUM Appoints Sara Toyloy as Independent Board Member
Sep 26, 2022 10:00am

PARIS, FRANCE and BOSTON, MA / ACCESSWIRE / September 26, 2022 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Sara Toyloy as its fourth independent member of the Board of Directors. Ms. Toyloy has over 30 years of experience in the medical device industry. In 2020, she founded Fabrica Consulting LLC, a medical device consulting firm providing global regulatory and clinical trial strategies, where she currently serves as president. Prior to this, she was at Elixir Medical Corporation for nearly 12 years, where she held several executive positions including President of New Therapies and Chief Regulatory Officer and Executive Vice President of Regulatory, Clinical and Quality. She also served as Executive Vice President of Biosensors International Group, and Vice President of Regulatory and Clinical Affairs at Medtronic Vascular. Ms. Toyloy began her career at Guidant Corporation (acquired by Boston Scientific in 2006) where she held several key roles, ultimately serving as Guidant''s Director of Regulatory Affairs and Clinical Research.

Dow futures: Stock market sells off as hawkish Fed sees new final price
Sep 22, 2022 01:21am

Dow futures fell overnight, along with S&P 500 futures and Nasdaq futures. The stock market fell sharply on Wednesday after the Federal Reserve rose strongly again and indicated a higher peak, or “ultimate” price. X This is a correction in the stock market. Investors should remain cautious, but look for leading names. Centennial collectibles ( CELH ), Shock Wave Medical ( SWAV ), ATI ( ATI ), GlobalFoundries ( GFS ) And the Energy Enphase ( ENPH ) They all show strong relative strength in a weak market. CELH and Shockwave Medical stock available at IBD Leaderboard Watch list. Celsius Holdings, Enphase and SWAV are in defect 50 . ENPH stock is in file IBD Big Cap 20 . It was a centenary on Wednesday IBD stock today while Shockwave was on Monday. The video included in this article discusses Wednesday’s market roller coaster movement and analyzes Celsius, ATI, and GFS stocks. Fed meeting As expected, the Fed raised its key interest rate by 75 basis points for the third consecutive meeting, and raised the target range to 3%-3.25%.

Source:Lanka Times
IBD Stock Of The Day: Why IBD 50 Leader Shockwave Soared In August — And Kept Going
Sep 19, 2022 17:48pm

Shockwave Medical is the IBD Stock Of The Day as its calcium-cracking efforts gain steam. SWAV stock is finding support at its 21-day line.

Source:Investor''s Business Daily
ShockWave Medical Inc. (NASDAQ: SWAV): A Great Stock To Watch
Sep 17, 2022 11:30am

ShockWave Medical Inc. (NASDAQ:SWAV) shares, rose in value on Friday, 09/16/22, with the stock price up by 0.51% to the previous day’s close as strong demand from buyers drove the stock to $285.41. Actively observing the price movement in the last trading, the stock closed the session at $283.95, falling within a range of $276.92 … ShockWave Medical Inc. (NASDAQ: SWAV): A Great Stock To Watch Read More »

Source:Stocks Register
SWAV stock falls as Oppenheimer downgrades (NASDAQ:SWAV)
Sep 06, 2022 15:39pm

Medical device maker ShockWave Medical (SWAV) lost ~5% in the morning hours Tuesday after Oppenheimer downgraded its shares to Underperform from Perform, citing overly…

Source:Seeking Alpha
Correcting and Replacing: Shockwave Medical to Participate in Two Upcoming Investor Conferences
Aug 31, 2022 20:05pm

SANTA CLARA, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on August 26, 2022, by Shockwave Medical, Inc. (NASDAQ: SWAV), please note that the fireside chat time for the Wells Fargo Healthcare Conference has been updated. The correct presentation time is 9:10 am Eastern Time. The details for the Morgan Stanley Healthcare Conference remain the same.

Looking Into ShockWave Medical''s Return On Capital Employed
Aug 31, 2022 13:56pm

According to Benzinga Pro, during Q2, ShockWave Medical (NASDAQ: SWAV ) earned $25.56 million, a 76.03% increase from the preceding quarter. ShockWave Medical also posted a total of $120.75 million in sales, a 28.96% increase since Q1. In Q1, ShockWave Medical earned $14.52 million, whereas sales reached $93.63 million. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a … Full story available on Benzinga.com

3 Healthcare Stocks That Are Beating the Market
Aug 28, 2022 13:29pm

Here''s why our roundtable is bullish on Shockwave Medical, Axsome Therapeutics, and Rhythm Pharmaceuticals.

Source:The Motley Fool
Big Money Likes ShockWave Medical
Aug 22, 2022 13:47pm

ShockWave Medical, Inc. (SWAV) stock has gained big this year, jumping 67.0% so far.

Source:FX Empire
Can ShockWave Medical Stock Climb Higher?
Aug 22, 2022 09:41am

Shares of this innovative healthcare stock are up by two-thirds this year. Investors want to know if there''s more fuel in the tank.

Source:The Motley Fool
ShockWave Medical (SWAV) Presents At 42nd Annual Global I Growth Conference - Slideshow (NASDAQ:SWAV)
Aug 18, 2022 16:24pm

The following slide deck was published by ShockWave Medical, Inc.

Source:Seeking Alpha
ShockWave Medical (SWAV) Investor Presentation - Slideshow (NASDAQ:SWAV)
Aug 18, 2022 16:23pm

The following slide deck was published by ShockWave Medical, Inc.

Source:Seeking Alpha
AMERICAN INTERNATIONAL GROUP, INC. Buys 1, Sells 4 in 2nd Quarter
Aug 14, 2022 21:00pm

Related Stocks: AAPL , CPT , SWAV , MSFT , AMZN ,

ShockWave shares hit record high as Q2 revenue more than doubles, co raises FY guidance
Aug 09, 2022 17:52pm

ShockWave Medical (SWAV) stock scaled a record high on Tuesday, after the cardiovascular medical device company reported Q2 sales that more than doubled Y/Y and raised its FY 2022…

Source:Seeking Alpha
Why ShockWave Medical Stock Is Soaring Today
Aug 09, 2022 16:38pm

Investors loved the company''s Q2 update.

Source:The Motley Fool
ShockWave Medical, Inc. (SWAV) CEO Doug Godshall on Q2 2022 Results - Earnings Call Transcript
Aug 09, 2022 02:02am

ShockWave Medical, Inc. (NASDAQ:NASDAQ:SWAV) Q2 2022 Results Conference Call August 08, 2022 4:30 PM ET Company Participants Debbie Kaster - VP, IR Doug Godshall - President, CEO Isaac…

Source:Seeking Alpha
ShockWave Medical (SWAV) Q2 2022 Earnings Call Transcript
Aug 09, 2022 01:00am

SWAV earnings call for the period ending June 30, 2022.

Source:The Motley Fool
Recap: ShockWave Medical Q2 Earnings
Aug 08, 2022 20:38pm

ShockWave Medical (NASDAQ: SWAV ) reported its Q2 earnings results on Monday, August 8, 2022 at 04:02 PM. Here''s what investors need to know about the announcement. Earnings ShockWave Medical beat estimated earnings by 54.55%, reporting an EPS of $0.68 versus … Full story available on Benzinga.com

Shockwave Medical Reports Second Quarter 2022 Financial Results
Aug 08, 2022 20:05pm

SANTA CLARA, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended June 30, 2022.

ShockWave Medical Q2 2022 Earnings Preview (NASDAQ:SWAV)
Aug 05, 2022 21:35pm

ShockWave Medical (SWAV) is scheduled to announce Q2 earnings results on Monday, August 8th, after market close.The consensus EPS Estimate is $0.22 and the consensus Revenue Estimate…

Source:Seeking Alpha